Home / Registry / Nephrology.asia
Available for Acquisition In Stock
Nephrology.asia

The domain name Nephrology.asia is officially available for purchase under registry record RR-Y8Z9-A0B1. RationalRegistry facilitates the formal transfer of legal title and ensures the asset is successfully delivered to the purchaser. All transaction funds are held by a secure escrow service of your choice to guarantee that the interests of both parties are protected throughout the entire process.

Acquisition Enquiry
$6,600
Asking price · USD

Formal response within one business day.

Asset Overview
Asking Price $6,600Audited Valuation
Settlement Secure Escrow Licensed Third-Party
Response < 24 Hours Business Enquiries
Asset Tenure Perpetual Ownership Rights
Registry Asset Record
Date of Record 05 Apr 2026 Archival Entry
Registry ID RR-Y8Z9-A0B1 Formal Record Entry
Asset Family .asia Regional TLD
Primary Sector Health and Life Sciences Kidney Medicine Speciality
Linguistic Scarcity Descriptive Moderate Scarcity
Market Signals nephrologykidney diseasedialysisrenal healthchronic kidney Semantic Acquisition Indicators
Rational Choice Evaluation
Market Signal
Costly signals reduce buyer uncertainty in asymmetric markets. A premium domain name functions as a verifiable commitment device.
7 / 10
Linguistic Scarcity
Premium names are finite. Supply is structurally fixed as demand expands, creating durable appreciation pressure.
7 / 10
Recall Efficiency
Memorability reduces search cost at every customer acquisition event, compounding brand value over time.
7 / 10
Economic Utility
Multi-functional capacity to anchor identity, reduce price elasticity, and lower customer acquisition cost across channels.
8 / 10
Strategic Longevity
Preserves the right to exploit future conditions across market cycles. Asset value is not dependent on any single use case.
8 / 10
Composite Score
Arithmetic mean across all five rational choice criteria. Reflects the overall investment grade of the asset.
7.4 / 10
Asset Audit

Nephrology.asia is audited as a Descriptive health asset anchoring the nephrology and renal medicine namespace across Asia-Pacific clinical and healthcare markets. Nephrology, the medical speciality focused on kidney function and disease, addresses conditions including chronic kidney disease, dialysis dependency, and renal transplantation. Asia carries a disproportionate burden of chronic kidney disease due to diabetes and hypertension prevalence, making nephrology services a high-demand speciality. Positional Advantage from owning the exact medical speciality under .asia provides Category Ownership Authority. Brand Education Cost is negligible for clinical and patient audiences. Market Liquidity is strong given demographic and disease burden drivers. Institutional acquirers include dialysis network operators, nephrology clinics, and renal care device companies. Nephrology.asia holds Category Ownership Authority over kidney medicine in Asian clinical markets.

Nephrology.asia applies the .asia extension's regional authority to kidney medicine and renal health services. The extension provides geographic specificity for nephrology clinic operators, dialysis networks, and renal care device providers across Asia-Pacific. Trust Premium from the exact medical speciality establishes Sector Authority Signal. Positional Advantage is sustained by chronic kidney disease burden across Asian populations.